Akebia Therapeutics
AKBA
AKBA
145 hedge funds and large institutions have $423M invested in Akebia Therapeutics in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 39 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
1.94% less ownership
Funds ownership: 77.36% → 75.42% (-1.9%)
5% less funds holding
Funds holding: 153 → 145 (-8)
29% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 28
Holders
145
Holding in Top 10
3
Calls
$9M
Puts
$662K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$7.16M | |
| 3 | +$4.29M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.9M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$3.04M |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$6.43M | |
| 3 | -$4.73M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$4.46M |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$3.12M |